phosphotyrosine has been researched along with n-oleoylethanolamine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canfrán-Duque, A; García-Oya, I; González-Yanes, C; Martínez de Ubago, M; Pérez-Pérez, A; Quintana-Portillo, R; Rodríguez de Fonseca, F; Sánchez-Margalet, V | 1 |
1 other study(ies) available for phosphotyrosine and n-oleoylethanolamine
Article | Year |
---|---|
Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Ligands; Liver Neoplasms; MAP Kinase Signaling System; Oleic Acids; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphotyrosine; PPAR alpha; Pyrimidines; Rats; Receptor, Insulin; Signal Transduction | 2009 |